Hispanic cancer mortality varies among ethnic groups
To interview Paulo Pinheiro, contact Julia Gunther at [email protected] or 215-446-6896.
Bottom Line: Cancer mortality rates vary considerably within the growing Hispanic population in the United States, with significant differences among the major Hispanic ethnic groups.
Journal in Which the Study was Published: Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Author: Paulo S. Pinheiro, MD, PhD, an associate professor of epidemiology at the School of Community Health Sciences at the University of Nevada, Las Vegas.
Background: Hispanics accounted for 17 percent of the U.S. population in 2014 and are expected to account for 29 percent of the population by 2060. Cancer is the leading cause of death among Hispanics. In general, cancer incidence and mortality rates are calculated on an aggregate basis, without separating the Hispanic population based on ethnicity or nation of origin.
However, Pinheiro pointed out, "Hispanic populations are all different, reflecting their country of origin, cultural experiences, and socioeconomic status. If we can detect the differences among them, we can more easily identify public health strategies that could decrease their cancer risk and improve health outcomes."
How the Study Was Conducted and Results: In order to compare cancer mortality among various Hispanic ethnic groups, Pinheiro and colleagues analyzed mortality data in Florida residents during the years 2008-2012. The researchers chose to base their study on Florida data because it is the only state with statistically significant representation from all major Hispanic ethnic groups: Cuban, Puerto Rican, Mexican, Central American, Dominican, and South American, Pinheiro said.
Overall, Pinheiro said, the study showed that Hispanics had a 30 percent lower risk of dying of cancer than non-Hispanic whites. Hispanics had higher mortality rates from stomach and prostate cancer, but lower rates for lung, pancreas, and breast cancer, compared with non-Hispanic whites. When the researchers examined mortality rates by ethnicity, they found wide variations among groups. Key findings:
- * Cubans had the highest overall mortality rate for both sexes: 174.1 deaths per 100,000 men and 104.1 deaths per 100,000 women, compared with 158.5 deaths per 100,000 among all Hispanic men and 99.6 per 100,000 for all Hispanic women.
By comparison, the mortality rate for non-Hispanic white men was 204.4 deaths per 100,000 and for non-Hispanic white women, the mortality rate was 144.8 deaths per 100,000.
Cubans had the highest lung cancer mortality rates of all ethnic groups, which Pinheiro attributed to high smoking prevalence.
* Puerto Ricans had the highest rates of liver cancer among all groups analyzed. Pinheiro said this group may benefit from efforts to increase awareness of risk factors for liver cancer, such as the hepatitis C virus.
* Cubans and Puerto Ricans had higher than average mortality rates from colorectal and endometrial cancers, two types that have been linked to obesity. Pinheiro said this reflects a tendency for immigrants to the United States to gain weight as they adopt a typical American diet. Cuban and Puerto Rican women also had higher mortality rates from breast cancer than the other groups. Pinheiro said these women tended to follow the American trend of having fewer children, which has been shown to increase breast cancer risk.
* Prostate cancer mortality among Dominicans was nearly double that of the non-Hispanic whites. Pinheiro said the disparity may reflect the fact that many Dominicans have African ancestry; prostate cancer incidence and mortality is higher in men of African descent.
Author Comment: Pinheiro said the study results suggest that as more Hispanics settle in the United States, they should be cautious about adopting the typical American diet.
"They would do well to remember the diets of their home countries," he said. "Rice and beans, grains, and fresh fruits and vegetables may be more beneficial than the food they will be exposed to in America."
He added that physicians should counsel their Hispanic patients to follow all recommendations for cancer screening.
"There is undoubtedly better access to screening here than in their home countries, so they should take advantage of it," Pinheiro said. "Depending on where they come from, their doctor could have a more targeted conversation about their cancer risk."
Pinheiro noted that Florida's Hispanic population is mostly foreign-born. He said he expects that the trends shown in this study would apply to Hispanics in most parts of the United States, but may differ in states like California and Texas, where many Hispanic families have lived for several generations.
Limitations: The amount of time spent in the United States was not available for each study participant, Pinheiro said.
Funding & Disclosures: This study was partially funded by the National Institute of General Medical Sciences. Pinheiro declares no conflicts of interest.
Follow us: Cancer Research Catalyst http://blog.aacr.org; Twitter @AACR; and Facebook http://www.facebook.com/aacr.org
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world's first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 37,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and patient advocates residing in 108 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 30 conferences and educational workshops, the largest of which is the AACR Annual Meeting with nearly 19,500 attendees. In addition, the AACR publishes eight prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit http://www.AACR.org.